Lindsay J. Celada, Ph.D. - Publications

Affiliations: 
2013 Biological Sciences Tennessee State University, Waverly, TN, United States 
Area:
Biochemistry, Immunology, Toxicology

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Celada SI, Lim CX, Carisey AF, Ochsner SA, Arce Deza CF, Rexie P, Poli De Frias F, Cardenas-Castillo R, Polverino F, Hengstschläger M, Tsoyi K, McKenna NJ, Kheradmand F, Weichhart T, Rosas IO, ... ... Celada LJ, et al. SHP2 promotes sarcoidosis severity by inhibiting SKP2-targeted ubiquitination of TBET in CD8 T cells. Science Translational Medicine. 15: eade2581. PMID 37703351 DOI: 10.1126/scitranslmed.ade2581  0.457
2018 Celada LJ, Kropski JA, Herazo-Maya JD, Luo W, Creecy A, Abad AT, Chioma OS, Lee G, Hassell NE, Shaginurova GI, Wang Y, Johnson JE, Kerrigan A, Mason WR, Baughman RP, et al. PD-1 up-regulation on CD4 T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production. Science Translational Medicine. 10. PMID 30257954 DOI: 10.1126/Scitranslmed.Aar8356  0.446
2017 Hawkins C, Shaginurova G, Shelton DA, Herazo-Maya JD, Oswald-Richter KA, Rotsinger JE, Young A, Celada LJ, Kaminski N, Sevin C, Drake WP. Local and Systemic CD4+ T Cell Exhaustion Reverses with Clinical Resolution of Pulmonary Sarcoidosis. Journal of Immunology Research. 2017: 3642832. PMID 29234685 DOI: 10.1155/2017/3642832  0.464
2016 Celada LJ, Rotsinger JE, Young A, Shaginurova G, Shelton D, Hawkins C, Drake WP. Programmed Death-1 Inhibition of PI3K/AKT/mTOR Signaling Impairs Sarcoidosis CD4+ T Cell Proliferation. American Journal of Respiratory Cell and Molecular Biology. PMID 27564547 DOI: 10.1165/Rcmb.2016-0037Oc  0.464
2015 Celada LJ, Drake WP. Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy? Immunotherapy. 7: 57-66. PMID 25572480 DOI: 10.2217/Imt.14.103  0.404
2014 Cato A, Celada L, Kibakaya EC, Simmons N, Whalen MM. Brominated flame retardants, tetrabromobisphenol A and hexabromocyclododecane, activate mitogen-activated protein kinases (MAPKs) in human natural killer cells. Cell Biology and Toxicology. 30: 345-360. PMID 25341744 DOI: 10.1007/S10565-014-9289-Y  0.358
2014 Braun NA, Celada LJ, Herazo-Maya JD, Abraham S, Shaginurova G, Sevin CM, Grutters J, Culver DA, Dworski R, Sheller J, Massion PP, Polosukhin VV, Johnson JE, Kaminski N, Wilkes DS, et al. Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity. American Journal of Respiratory and Critical Care Medicine. 190: 560-71. PMID 25073001 DOI: 10.1164/Rccm.201401-0188Oc  0.446
2014 Celada LJ, Whalen MM. Effects of butyltins on mitogen-activated-protein kinase kinase kinase and Ras activity in human natural killer cells. Journal of Applied Toxicology : Jat. 34: 1002-11. PMID 24038145 DOI: 10.1002/Jat.2921  0.338
Show low-probability matches.